1910 Genetics Alternatives & Competitors
12 companies similar to 1910 Genetics — Advancing small and large molecule drug discovery with a multimodal AI platform...
Companies similar to 1910 Genetics
Manifold Bio
Organism-scale intelligence, designed in vivo
Harmonic Discovery
Embedding the complexity of disease into the drug discovery process
Myricx Bio
Developing a new class of ADCs based on NMT inhibition to treat cancer
Rgenta Therapeutics Inc.
We unlock the therapeutic potentials of highly disease-relevant targets undruggable by sma...
Rival Readout
Competing with 1910 Genetics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Arcus Biosciences
Biopharmaceutical company developing differentiated molecules and combination therapies fo...
Mosaic TX
Resolving cancer's complexity through the power of targeted drug combinations
Oxford BioTherapeutics
Redefining the cancer-immune synapse for novel immune checkpoint mechanisms
iktos
Artificial intelligence for new drug design
Integrated Biosciences, Inc.
Unravelling complex biology with optogenetics, chemistry and computation for small molecul...
Genesis Molecular AI
Unifying AI and Biotech to accelerate the discovery of new medicines
Ventus Therapeutics
Pioneering a unique approach to structure-based drug discovery. Located in Waltham, MA and...
About 1910 Genetics
1910 Genetics is a pioneering biotechnology company established in 2018, setting itself apart by utilizing a multimodal AI platform to advance both small and large molecule drug discovery. The company integrates AI with three proprietary datasets—computational, wet lab proxy biological, and wet lab ground truth biologi...
AI-enabled drug discovery, Integration of AI models with lab automation, Macrocyclic peptide drug development, Predictive modeling for CNS penetration
Biotech companies, Pharmaceutical companies, Research institutions, Drug development organizations
AI-driven Drug Discovery, Small Molecule Therapeutics, Large Molecule Therapeutics, Multimodal AI Platform, Laboratory Automation, Neurological Disease Research, Autoimmune Disease Research, Cancer Therapy Development, Computational Biology, Biotech Innovation, Pharmaceutical Partnerships, Data-driven Drug Development, Biological Automation, Protein Therapeutics
B2B, Platform, SaaS
Licensing, Subscription, Project Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around 1910 Genetics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at 1910 Genetics on 15 Jun 2026. The 12 companies listed here were last checked between 28 Jan 2026 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.